Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyh-Pyng Gau

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Scientific Reports|August 15, 2019
Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantationYao-Chung Liu, Yi-Hsin Chou, Po-Shen Ko, et al.
Internal Medicine (Tokyo, Japan)|January 17, 2014
Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 yearsYao-Chung Liu, Jyh-Pyng Gau, Yuan-Bin Yu, et al.
Annals of Hematology|January 21, 2014
Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopeniaMing-Hung Hu, Yuan-Bin Yu, Yu-Chung Huang, et al.
Hematological Oncology|October 28, 2022
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignanciesJing-Gu Jiang, Chia-Jen Liu, Chiu-Mei Yeh, et al.
Cancer Medicine|January 17, 2023
Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experienceHao-Yuan Wang, Ching-Fen Yang, Chia-Hsin Lin, et al.
European Journal of Haematology|October 7, 2011
Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myelomaLiang-Tsai Hsiao, Ching-Fen Yang, Sheng-Hsiang Yang, et al.
Blood Cells, Molecules & Diseases|May 16, 2015
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutationJyh-Pyng Gau, Chih-Cheng Chen, Yi-Sheng Chou, et al.
Blood Neoplasia|January 15, 2026
Ratios of CD8 T lymphocytes to M-MDSCs (CD8MMR) predict prognosis in patients with untreated DLBCLHao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, et al.
Haematologica|January 7, 2017
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in <i>JAK2</i>-mutated myeloproliferative neoplasmsChih-Cheng Chen, Jie-Yu You, Jrhau Lung, et al.
Cancer Medicine|September 21, 2022
Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patientsWen-Ying Lin, Chun-Kuang Tsai, Chiu-Mei Yeh, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Scientific Reports|August 15, 2019
Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantationYao-Chung Liu, Yi-Hsin Chou, Po-Shen Ko, et al.
Internal Medicine (Tokyo, Japan)|January 17, 2014
Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 yearsYao-Chung Liu, Jyh-Pyng Gau, Yuan-Bin Yu, et al.
Annals of Hematology|January 21, 2014
Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopeniaMing-Hung Hu, Yuan-Bin Yu, Yu-Chung Huang, et al.
Hematological Oncology|October 28, 2022
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignanciesJing-Gu Jiang, Chia-Jen Liu, Chiu-Mei Yeh, et al.
Cancer Medicine|January 17, 2023
Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experienceHao-Yuan Wang, Ching-Fen Yang, Chia-Hsin Lin, et al.
European Journal of Haematology|October 7, 2011
Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myelomaLiang-Tsai Hsiao, Ching-Fen Yang, Sheng-Hsiang Yang, et al.
Blood Cells, Molecules & Diseases|May 16, 2015
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutationJyh-Pyng Gau, Chih-Cheng Chen, Yi-Sheng Chou, et al.
Blood Neoplasia|January 15, 2026
Ratios of CD8 T lymphocytes to M-MDSCs (CD8MMR) predict prognosis in patients with untreated DLBCLHao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, et al.
Haematologica|January 7, 2017
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in <i>JAK2</i>-mutated myeloproliferative neoplasmsChih-Cheng Chen, Jie-Yu You, Jrhau Lung, et al.
Cancer Medicine|September 21, 2022
Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patientsWen-Ying Lin, Chun-Kuang Tsai, Chiu-Mei Yeh, et al.
Pageof 13